...
首页> 外文期刊>Acta biomaterialia >Enzymatically degradable poly(ethylene glycol) hydrogels for the 3D culture and release of human embryonic stem cell derived pancreatic precursor cell aggregates
【24h】

Enzymatically degradable poly(ethylene glycol) hydrogels for the 3D culture and release of human embryonic stem cell derived pancreatic precursor cell aggregates

机译:可酶降解的聚乙二醇水凝胶,用于3D培养和人类胚胎干细胞来源的胰腺前体细胞聚集体的释放

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

This study aimed to develop a three dimensional culture platform for aggregates of human embryonic stem cell (hESC)-derived pancreatic progenitors that enables long-term culture, maintains aggregate size and morphology, does not adversely affect differentiation and provides a means for aggregate recovery. A platform was developed with poly(ethylene glycol) hydrogels containing collagen type I, for cell-matrix interactions, and peptide crosslinkers, for facile recovery of aggregates. The platform was first demonstrated with RIN-m5F cells, showing encapsulation and subsequent release of single cells and aggregates without adversely affecting viability. Aggregates of hESC-derived pancreatic progenitors with an effective diameter of 82 (15) pm were either encapsulated in hydrogels or cultured in suspension for 28 days. At day 14, aggregate viability was maintained in the hydrogels, but significantly reduced (88%) in suspension culture. However by day 28, viability was reduced under both culture conditions. Aggregate size was maintained in the hydrogels, but in suspension was significantly higher (similar to 2-fold) by day 28. The ability to release aggregates followed by a second enzyme treatment to achieve single cells enabled assessment by flow cytometry. Prior to encapsulation, there were 39% Pdx1(+)/Nkx6.1(+) cells, key endocrine markers required for beta-cell maturation. The fraction of doubly positive cells was not affected in hydrogels but was slightly and significantly lower in suspension culture by 28 days. In conclusion, we demonstrate that a MMP-sensitive PEG hydrogel containing collagen type I is a promising platform for hESC-derived pancreatic progenitors that maintains viable aggregates, aggregate size, and progenitor state and offers facile recovery of aggregates. (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
机译:这项研究旨在为人类胚胎干细胞(hESC)衍生的胰腺祖细胞的聚集体开发一个三维培养平台,该平台能够进行长期培养,保持聚集体的大小和形态,不会对分化产生不利影响,并且为聚集体的回收提供了一种手段。开发了一个平台,该平台使用了包含I型胶原蛋白(用于细胞基质相互作用)和肽交联剂(用于方便回收聚集体)的聚乙二醇水凝胶。该平台首次使用RIN-m5F细胞进行了展示,显示了单个细胞和聚集体的包囊和随后释放,而没有对生存能力产生不利影响。将有效直径为82(15)pm的hESC来源的胰腺祖细胞集合体封装在水凝胶中或悬浮培养28天。在第14天,在水凝胶中维持了总生存力,但是在悬浮培养中显着降低了(88%)。但是,到第28天,两种培养条件下的活力都降低了。在水凝胶中可以保持聚集体的大小,但是到28天悬浮液中的聚集体明显更高(类似于2倍)。释放聚集体的能力,然后进行第二次酶处理以达到单细胞的能力,可以通过流式细胞术进行评估。封装之前,有39%Pdx1(+)/ Nkx6.1(+)细胞,这是β细胞成熟所需的关键内分泌标记物。在水凝胶中,双阳性细胞的比例不受影响,但在悬浮培养中28天时则略有降低。总之,我们证明了含有I型胶原的MMP敏感PEG水凝胶是hESC衍生的胰腺祖细胞的有前途的平台,可维持可行的聚集体,聚集体大小和祖细胞状态,并提供聚集体的简便回收。 (C)2015 Acta Materialia Inc.,由Elsevier Ltd.发行。保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号